Dechra Veterinary Products has announced a new lower recommended starting dose of Vetoryl (trilostane), its treatment for dogs with Cushing's syndrome.

Dechra says the change to the Summary of Product Characteristics for Vetoryl Hard Capsules for…

Dechra Veterinary Products has announced that it will be launching Zycortal, a new medication for the treatment of canine hypoadrenocorticism at the BSAVA Congress in April.

Zycortal is a prolonged-release suspension used as replacement therapy for mineralocorticoid…

Dechra Veterinary Products has launched 5 mg Prednicortone (prednisolone) which can be split into increments of 1.25 mg using SmartTab technology.

Dechra says the ability to split Prednicortone into 1.25 mg doses is particularly useful when used alongside…

Dechra Veterinary Products has published a new series of video presentations about the diagnosis and treatment of canine hypoadrenocorticism.

The six videos, which were recorded by Dechra's technical team, range in length from 10 minutes to 37 minutes…

Dechra Veterinary Products has launched a competition for veterinary professionals in which you could win an Apple Watch for watching a two-minute video presentation about Felimazole, its treatment for feline hyperthyroidism, and answering three questions…

Dechra Veterinary Products has launched Laxatract, the UK’s first veterinary-licensed lactulose oral syrup to tackle constipation in cats and dogs.

Laxatract is indicated for the treatment of constipation and symptomatic treatment of diseases which…

Dechra Veterinary Products has announced that it has acquired Dilaterol, the oral bronchodilator for horses, from the Dutch veterinary pharma company, LeVet.

Dilaterol is an oral syrup containing 25 mgs/ml clenbuterol hydrochloride, indicated to treat respiratory…

Dechra has taken over the distribution of two products designed to support kidney health in senior cats, Porus One and its sister product Add One.

Porus One contains renaltec, a selective absorber that absorbs the precursors of uraemic toxins in the cat…

Dechra has launched Equisolon Jar, a new presentation of its oral prednisone powder for the treatment of severe equine asthma.

Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters…

Dechra (the maker of Vetoryl) has launched 'Prime Suspects', a nationwide campaign to raise awareness of Cushing’s syndrome amongst dog owners and drive them to vet practices for diagnosis and treatment.

The company points to a survey of 1000…

Dechra has launched Pergocoat, for the treatment of Pituitary Pars Intermedia Dysfunction (PPID), aka equine Cushing’s disease.

Pergocoat contains pergolide, a long-acting dopamine receptor agonist.

It is available in 0.5mg (off-white) and 1mg (yellow…

Dechra has launched a Cushing’s treatment and monitoring app to support owners prescribed Vetoryl for their dog.

The free app is designed to help to track changes and improvements in a dog’s health during treatment. 

The app uses questionnaires…

Dechra has launched ‘They’ve got Cushing’s. You’ve got us’ marketing campaign to highlight the company’s support for Vetoryl.

Across Europe, the company has over 30 technical experts who get over 2,500 technical calls…

Dechra has launched Felimazole Oral Solution 5mg/ml (thiamazole) for the stabilisation of hyperthyroidism in cats prior to surgical thyroidectomy and for the long-term treatment of feline hyperthyroidism.

The new presentation is honey-flavoured and is available…

Dechra is launching a double-divisible version of Vetoryl Flavoured Tablets for dogs with Cushing's.

The range will include Vetoryl 20mg, 30mg and 60mg hydrolysed chicken flavoured tablets, which can be broken into halves or quarters.

The new Vetoryl tablets…